EUVIMEDEUVIMED entdecken
Crossref

CRISPR/Cas9-mediated A4GALT suppression rescues Fabry disease phenotypes in a kidney organoid model

Sheng Cui, Yoo Jin Shin, Xianying Fang, Hanbi Lee, Sang Hun Eum, Eun Jeong Ko, Sun Woo Lim, Eunji Shin, Kang In Lee, Jae Young Lee, Chae Bin Lee, Soo Kyung Bae und 2 weitere

Translational Research · 2023-08 · 258 · 35-46

DOI: 10.1016/j.trsl.2023.02.005 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Translational Research, 2023-08. Verfasst von Sheng Cui und 13 weiteren Autor:innen. Beteiligte Einrichtung: Transplantation Research Center, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Fabry Disease, Induced Pluripotent Stem Cells, Kidney Diseases. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 59 Literaturangaben. Gefördert von: Ministry of Health and Welfare, National Research Foundation of Korea, Ministry of Education, Science and Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fabry DiseaseInduced Pluripotent Stem CellsKidney DiseasesHumansCRISPR-Cas SystemsKidneyPhenotypeOrganoids

Stichwörter der Autor:innen

A4GALTCRISPR/Cas9Fabry diseaseGLAGb-3

Autor:innen und Institutionen

  • Transplantation Research Center, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
  • Transplantation Research Center, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea; Division of Nephrology, Department of Internal Medicine, Seoul St. Mary's Hosp…
  • Transplantation Research Center, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea; Division of Nephrology, Department of Internal Medicine, Incheon St. Mary's Ho…
  • ToolGen, Inc., Seoul, Republic of Korea.
  • College of Pharmacy and Integrated Research Institute of Pharmaceutical Sciences, The Catholic University of Korea, Bucheon, Republic of Korea.

Förderung

  • Ministry of Health and Welfare
  • National Research Foundation of Korea
  • Ministry of Education, Science and Technology

Zitieren

APA

Cui, S., Shin, Y. J., Fang, X., Lee, H., Eum, S. H., Ko, E. J., Lim, S. W., Shin, E., Lee, K. I., Lee, J. Y., Lee, C. B., Bae, S. K., Yang, C. W., & Chung, B. H. (2023). CRISPR/Cas9-mediated A4GALT suppression rescues Fabry disease phenotypes in a kidney organoid model. Translational Research, 258, 35-46. https://doi.org/10.1016/j.trsl.2023.02.005

Vancouver

Cui S, Shin YJ, Fang X, Lee H, Eum SH, Ko EJ, et al. CRISPR/Cas9-mediated A4GALT suppression rescues Fabry disease phenotypes in a kidney organoid model. Translational Research. 2023;258:35-46. doi:10.1016/j.trsl.2023.02.005

BibTeX
@article{Cui2023,
  author = {Cui, Sheng and Shin, Yoo Jin and Fang, Xianying and Lee, Hanbi and Eum, Sang Hun and Ko, Eun Jeong and Lim, Sun Woo and Shin, Eunji and Lee, Kang In and Lee, Jae Young and Lee, Chae Bin and Bae, Soo Kyung and Yang, Chul Woo and Chung, Byung Ha},
  title = {CRISPR/Cas9-mediated A4GALT suppression rescues Fabry disease phenotypes in a kidney organoid model},
  journal = {Translational Research},
  year = {2023},
  volume = {258},
  pages = {35--46},
  doi = {10.1016/j.trsl.2023.02.005}
}
Kostenlos starten →